HCA Healthcare, Inc. (HCA) Analyst Ratings & Price Targets

HCA Healthcare, Inc.

HCA · NYSE

Analyst Consensus

Buy

23 analysts

$410

Current

—

Low

$463

Average

—

High

Average target implies +12.75% versus the current price.

The ratings synthesis for HCA has not been generated yet.

Rating Actions

No individual rating actions have been captured for HCAyet. Consensus figures above come from Nasdaq's aggregate feed.

Rating actions are extracted from published reporting. Each row links to its source.

Covering Firms

ARGUS RESEARCH

B OF A GLBL RES

BARCLAYS CAPITA

CANTOR FITZGERA

CITIGROUP

CO FORECST

DEUTSCHE BK SEC

GOLDMAN SACHS

JEFFERIES & CO.

JP MORGAN SECUR

LEERINK PARTNRS

LOOP CAPITAL MK

MIZUHO SECURITI

OPPENHEIMER HLD

RAYMOND JAMES

RBC CAPITAL

SANFORD BERNSTE

STEPHENS INC

TD COWEN

TRUIST SECURITI

UBS

WELLS FARGO SEC

ZACKS RESEARCH

Symbol: HCA
Type: Stock
Sector: Health Care
Industry: Hospital/Nursing Management
Country: North America
Exchange: NYSE

Nashville-based HCA Healthcare is one of the nation's leading providers of healthcare services comprising 189 hospitals and approximately 2,600 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 19 states and the United Kingdom. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine. HCA Healthcare has conducted a number of clinical studies, including one that demonstrated that full-term delivery is healthier than early elective delivery of babies and another that identified a clinical protocol that can reduce bloodstream infections in ICU patients by 44%. HCA Healthcare is a learning health system that uses its approximately 47 million annual patient encounters to advance science, improve patient care and save lives.

Analyst Consensus

See all

Buy